# PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)

> **NCT05763602** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Loreen Herwaldt** · enrollment: 2000 (estimated)

## Conditions studied

- Surgical Site Infection

## Interventions

- **DRUG:** povidone-iodine topical ointment

## Key facts

- **NCT ID:** NCT05763602
- **Lead sponsor:** Loreen Herwaldt
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-09-15
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05763602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05763602, "PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05763602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*